<DOC>
	<DOCNO>NCT01709630</DOCNO>
	<brief_summary>Determine significant correlation maternal serum magnesium level , maternal neonatal outcome .</brief_summary>
	<brief_title>PK/PD Modeling Magnesium Mother Neonate</brief_title>
	<detailed_description>We construct pharmacokinetic pharmacodynamic model intravenous magnesium sulfate administer antenatally expectant mother expose fetus aim optimize maternal fetal outcome prevent maternal neonatal overdose morbidity associate current magnesium treatment protocol . Once developed PK/PD model hospital cohort , apply model large exist NICHD database mathematically calculate optimal dosing protocol .</detailed_description>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Pregnant woman age 1845 year Magnesium sulfate exposure preeclampsia , tocolysis , neuroprotection Neonates ( male female ) born 2442 week gestation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>